Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Genpact LTDG · Entity 3760 | Director | April 23, 2026 | April 27, 2026 |
| WELLS FARGO & COMPANY/MNWFC · Entity 2824 | Director | April 28, 2026 | April 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Genpact LTD
Report date April 23, 2026 · Filed April 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 64,281 |
Reported balance
After 2026-04-23 transaction · row 1
1 source rowRow 1 · 2026-04-23 · Grant · Acquired 6,521 · Balance 64,281 F1: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.
WELLS FARGO & COMPANY/MN
Report date April 28, 2026 · Filed April 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock UnitsSEC Table II · derivative / convertible security | Direct | 17,851.9647 |
Reported balance
After 2026-04-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-28 · Grant · Acquired 3,436 · Balance 17,851.9647 F1: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F2: Each Common Stock Unit represents a right to receive one share of Company common stock. F3: Includes dividend equivalents reinvested in additional Common Stock Units. |
| Common Stock, $1 2/3 Par ValueSEC Table I · non-derivative | Direct | 100 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 100 |
Filing footnotes · ownership attribution and instrument terms
F1: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director.
F2: Each Common Stock Unit represents a right to receive one share of Company common stock.
F3: Includes dividend equivalents reinvested in additional Common Stock Units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Alteryx, Inc.
Report date March 19, 2024 · Filed March 19, 2024
Section 16 reporting ended · disclosed 2024-03-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2024-03-19 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-03-19 · Disposition to issuer · Disposed 9,308 · Balance 7,495 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated December 18, 2023, by and among Alteryx, Inc. (the "Issuer"), Azurite Intermediate Holdings, Inc. ("Parent") and Azurite Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. F2: At the effective time of the Merger, these shares were automatically converted solely into the right to receive cash in an amount equal to $48.25, without interest, per share (the "Per Share Price"), subject to the terms and conditions of the Merger Agreement. Row 2 · 2024-03-19 · Disposition to issuer · Disposed 7,495 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated December 18, 2023, by and among Alteryx, Inc. (the "Issuer"), Azurite Intermediate Holdings, Inc. ("Parent") and Azurite Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. F3: Pursuant to the Merger Agreement and the Issuer's non-employee director compensation policy, effective as of the effective time of the Merger, this unvested award of restricted stock units was cancelled and converted solely into the right to receive an amount in cash (without interest) equal to (i) the total number of shares of common stock subject to such restricted stock unit award immediately prior to the effective time of the Merger, multiplied by (ii) the Per Share Price. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated December 18, 2023, by and among Alteryx, Inc. (the "Issuer"), Azurite Intermediate Holdings, Inc. ("Parent") and Azurite Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent.
F2: At the effective time of the Merger, these shares were automatically converted solely into the right to receive cash in an amount equal to $48.25, without interest, per share (the "Per Share Price"), subject to the terms and conditions of the Merger Agreement.
F3: Pursuant to the Merger Agreement and the Issuer's non-employee director compensation policy, effective as of the effective time of the Merger, this unvested award of restricted stock units was cancelled and converted solely into the right to receive an amount in cash (without interest) equal to (i) the total number of shares of common stock subject to such restricted stock unit award immediately prior to the effective time of the Merger, multiplied by (ii) the Per Share Price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2026 Filed Apr 30, 2026 21:07 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock Units · Derivative | 3,436 | $81.50 | $280,034.00 |
DisclosureSEC source: 0000072971-26-000239 · form4.xml · derivative · entry 2 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,851.9647 Underlying: Common Stock, $1 2/3 Par Value · 3,436 shares Expires not disclosed F1 · security: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F2 · derivative.exercise_price: Each Common Stock Unit represents a right to receive one share of Company common stock. F1 · derivative.exercise_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F1 · derivative.expiration_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F3 · balance_after: Includes dividend equivalents reinvested in additional Common Stock Units. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 20:25 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 6,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001367198-26-000002 · wk-form4_1777321530.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,281 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:59 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 4,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001398659-25-000073 · wk-form4_1748379593.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,760 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026. Read SEC document |
| April 29, 2025 Filed May 1, 2025 21:27 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock Units · Derivative | 3,728 | $71.10 | $265,060.80 |
DisclosureSEC source: 0001127602-25-012990 · form4.xml · derivative · entry 2 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,108.4723 Underlying: Common Stock, $1 2/3 Par Value · 3,728 shares Expires not disclosed F1 · security: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F2 · derivative.exercise_price: Each Common Stock Unit represents a right to receive one share of Company common stock. F1 · derivative.exercise_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F1 · derivative.expiration_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F3 · balance_after: Includes dividend equivalents reinvested in additional Common Stock Units. Read SEC document |
| May 02, 2024 Filed May 6, 2024 20:24 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 6,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001398659-24-000071 · wk-form4_1715027033.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,935 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2024 and will be settled in common shares on December 31, 2025. Read SEC document |
| April 30, 2024 Filed May 2, 2024 20:44 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock Units · Derivative | 4,046 | $59.32 | $240,008.72 |
DisclosureSEC source: 0001127602-24-014006 · form4.xml · derivative · entry 2 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,106.1884 Underlying: Common Stock, $1 2/3 Par Value · 4,046 shares Expires not disclosed F1 · security: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F2 · derivative.exercise_price: Each Common Stock Unit represents a right to receive one share of Company common stock. F1 · derivative.exercise_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F1 · derivative.expiration_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. Read SEC document |
| March 19, 2024 Filed Mar 19, 2024 16:36 UTC | Alteryx, Inc. AYX · Entity 92794 | Disposition to issuerClass A Common Stock | 7,495 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001689923-24-000026 · wk-form4_1710880572.xml · nonDerivative · entry 2 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated December 18, 2023, by and among Alteryx, Inc. (the "Issuer"), Azurite Intermediate Holdings, Inc. ("Parent") and Azurite Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. F3 · price: Pursuant to the Merger Agreement and the Issuer's non-employee director compensation policy, effective as of the effective time of the Merger, this unvested award of restricted stock units was cancelled and converted solely into the right to receive an amount in cash (without interest) equal to (i) the total number of shares of common stock subject to such restricted stock unit award immediately prior to the effective time of the Merger, multiplied by (ii) the Per Share Price. Read SEC document |
| March 19, 2024 Filed Mar 19, 2024 16:36 UTC | Alteryx, Inc. AYX · Entity 92794 | Disposition to issuerClass A Common Stock | 9,308 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001689923-24-000026 · wk-form4_1710880572.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,495 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated December 18, 2023, by and among Alteryx, Inc. (the "Issuer"), Azurite Intermediate Holdings, Inc. ("Parent") and Azurite Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. F2 · price: At the effective time of the Merger, these shares were automatically converted solely into the right to receive cash in an amount equal to $48.25, without interest, per share (the "Per Share Price"), subject to the terms and conditions of the Merger Agreement. Read SEC document |
| December 07, 2023 Filed May 10, 2024 20:18 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GiftCommon Stock, $1 2/3 Par Value | 210 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-014993 · form4.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100 F1 · kind: The gifted shares were previously held in a managed account. Read SEC document |
| May 17, 2023 Filed May 18, 2023 18:49 UTC | Alteryx, Inc. AYX · Entity 92794 | GrantClass A Common Stock | 5,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001689923-23-000040 · wf-form4_168445017049096.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,803 F1 · shares: Represents an annual award of restricted stock units ("RSUs") to the non-employee directors (the "Annual Award") of Alteryx, Inc. (the "Issuer"). The Annual Award shall fully vest on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 17, 2024, in each case, so long as the non-employee director continues to provide services to the Issuer through such date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting. F1 · price: Represents an annual award of restricted stock units ("RSUs") to the non-employee directors (the "Annual Award") of Alteryx, Inc. (the "Issuer"). The Annual Award shall fully vest on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 17, 2024, in each case, so long as the non-employee director continues to provide services to the Issuer through such date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting. F2 · balance_after: Includes 9,469 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:11 UTC | Genpact LTD G · Entity 3760 | PurchaseCommon Shares | 5,000 | $36.93 | $184,641.50 |
DisclosureSEC source: 0001140361-23-025014 · form4.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,228 F1 · price: The price in Column 4 is a weighted average price. The actual purchase prices for these transactions ranged from $36.91 to $36.94. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:13 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 4,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023501 · form4.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,228 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2023 and will be settled in common shares on December 31, 2024. Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 21:27 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock Units · Derivative | 5,919 | $40.55 | $240,015.45 |
DisclosureSEC source: 0001127602-23-013679 · form4.xml · derivative · entry 2 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,919 Underlying: Common Stock, $1 2/3 Par Value · 5,919 shares Expires not disclosed F1 · security: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F2 · derivative.exercise_price: Each Common Stock Unit represents a right to receive one share of Company common stock. F1 · derivative.exercise_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. F1 · derivative.expiration_date: Common Stock Units vested upon grant with settlement deferred until the later of termination of service as a director of Wells Fargo & Company (the "Company") or such later settlement date elected by the director. Read SEC document |
| May 25, 2022 Filed May 27, 2022 17:12 UTC | Alteryx, Inc. AYX · Entity 92794 | GrantClass A Common Stock | 3,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001689923-22-000053 · wf-form4_165368594283666.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,283 F1 · shares: Represents an annual award of restricted stock units ("RSUs") to the non-employee directors (the "Annual Award") of Alteryx, Inc. (the "Issuer"). The Annual Award shall fully vest on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 25, 2023, in each case, so long as the non-employee director continues to provide services to the Issuer through such date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting. F1 · price: Represents an annual award of restricted stock units ("RSUs") to the non-employee directors (the "Annual Award") of Alteryx, Inc. (the "Issuer"). The Annual Award shall fully vest on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 25, 2023, in each case, so long as the non-employee director continues to provide services to the Issuer through such date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting. F2 · balance_after: Includes 9,556 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting. Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:20 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 4,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-011513 · doc1.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,312 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2022 and will be settled in common shares on December 31, 2023. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 17:05 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 5,284 | $44.58 | $235,560.72 |
DisclosureSEC source: 0001127602-22-012643 · form4.xml · derivative · entry 2 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,284 Underlying: Common Stock, $1 2/3 Par Value · 5,284 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 17:05 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock, $1 2/3 Par Value | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012643 · form4.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 17:41 UTC | Alteryx, Inc. AYX · Entity 92794 | GrantClass A Common Stock | 1,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001689923-21-000111 · wf-form4_163891687684523.xml · nonDerivative · entry 2 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,651 F3 · shares: Represents an award of RSUs. The RSUs vest as to 100% of the shares on the earlier of: (i) the date of the next annual meeting of the Issuer's stockholders and (ii) December 6, 2022, subject to the continuing service of the Reporting Person on the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting. F4 · balance_after: Includes 7,651 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 17:41 UTC | Alteryx, Inc. AYX · Entity 92794 | GrantClass A Common Stock | 5,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001689923-21-000111 · wf-form4_163891687684523.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,924 F1 · shares: Represents an award of restricted stock units ("RSUs"). The RSUs vest over 3 years in equal annual installments beginning on December 6, 2022, subject to the continuing service of the Reporting Person on each vesting date. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting. F2 · balance_after: Includes 5,924 unvested shares subject to awards of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting. Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:12 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 3,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-009308 · doc1.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,483 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2021 and will be settled in common shares on December 31, 2022. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:10 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 5,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-010996 · doc1.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,774 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2020 and will be settled in common shares on December 31, 2021. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:20 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 3,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-010575 · doc1.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,662 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2019 and will be settled in common shares on December 31, 2020. Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:30 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 3,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022802 · doc1.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,336 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2018 and will be settled in common shares on December 31, 2019. Read SEC document |
| May 09, 2017 Filed May 11, 2017 20:11 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-019751 · doc1.xml · nonDerivative · entry 1 Morken CeCelia · CIK 0001367198 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,375 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2017 and will be settled in common shares on December 31, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.